A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03986931|
Recruitment Status : Recruiting
First Posted : June 14, 2019
Last Update Posted : April 27, 2021
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Linnea Polgreen, University of Iowa
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Recruiting|
|Estimated Primary Completion Date :||December 2021|
|Estimated Study Completion Date :||July 2022|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Palmer MJ, Machiyama K, Woodd S, Gubijev A, Barnard S, Russell S, Perel P, Free C. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults. Cochrane Database Syst Rev. 2021 Mar 26;3:CD012675. doi: 10.1002/14651858.CD012675.pub3.
Polgreen LA, Carter BL, Polgreen PM, Snyder PM, Sewell DK, Bayman EO, Francis SL, Simmering JE, Parker C, Finkelstein R. A pharmacist intervention for monitoring and treating hypertension using bidirectional texting: PharmText BP. Contemp Clin Trials. 2020 Nov;98:106169. doi: 10.1016/j.cct.2020.106169. Epub 2020 Oct 7.